Puma Biotechnology Presents Final Results from the Biliary Tract Cohort of the Phase 2 SUMMIT 'Basket' Trial of Neratinib at the ASCO 2022 Annual Meeting
![Amazon.co.jp: PUMA(プーマ) Trial Piste 653658-653659-02-01 Men's Top and Bottom Set, Puma Red, Size M : Clothing, Shoes & Jewelry Amazon.co.jp: PUMA(プーマ) Trial Piste 653658-653659-02-01 Men's Top and Bottom Set, Puma Red, Size M : Clothing, Shoes & Jewelry](https://m.media-amazon.com/images/I/51SaJAc-1PL._AC_.jpg)
Amazon.co.jp: PUMA(プーマ) Trial Piste 653658-653659-02-01 Men's Top and Bottom Set, Puma Red, Size M : Clothing, Shoes & Jewelry
![Puma Biotechnology, Inc. - Puma Biotechnology Presents Results from the Phase II SUMMIT Trial of Neratinib for ERBB2 (HER2) Mutant, HER2 Non-Amplified, Metastatic Breast Cancer at the 2019 San Antonio Breast Cancer Puma Biotechnology, Inc. - Puma Biotechnology Presents Results from the Phase II SUMMIT Trial of Neratinib for ERBB2 (HER2) Mutant, HER2 Non-Amplified, Metastatic Breast Cancer at the 2019 San Antonio Breast Cancer](https://mms.businesswire.com/media/20191211005896/en/762417/4/Untitled-1.jpg)
Puma Biotechnology, Inc. - Puma Biotechnology Presents Results from the Phase II SUMMIT Trial of Neratinib for ERBB2 (HER2) Mutant, HER2 Non-Amplified, Metastatic Breast Cancer at the 2019 San Antonio Breast Cancer
Puma Biotechnology Presents Updated Findings from the Phase II SUMMIT Basket Trial of Neratinib in EGFR Exon 18-Mutant NSCLC at the 2022 EORTC/NCI/AACR Symposium
![Female puma (Puma concolor) in shrubland of site 1 during high food... | Download Scientific Diagram Female puma (Puma concolor) in shrubland of site 1 during high food... | Download Scientific Diagram](https://www.researchgate.net/profile/Juan-Esparza-Carlos/publication/325404799/figure/fig2/AS:642893039538183@1530289053852/Female-puma-Puma-concolor-in-shrubland-of-site-1-during-high-food-trial-4-April.png)
Female puma (Puma concolor) in shrubland of site 1 during high food... | Download Scientific Diagram
![Puma Biotechnology Presents Updated Results from the Phase II SUMMIT Trial of Neratinib for HER2-Mutant, HR-Positive Metastatic Breast Cancer at SABCS 2020 | Business Wire Puma Biotechnology Presents Updated Results from the Phase II SUMMIT Trial of Neratinib for HER2-Mutant, HR-Positive Metastatic Breast Cancer at SABCS 2020 | Business Wire](https://mms.businesswire.com/media/20201209005093/en/845229/4/4788079_PD1-05_Jhaveri_SUMMIT_breast_SABCS_2020_poster_FINAL.jpg)